RxBalance Ad-Style Campaigns

We are passionate about helping doctors, patients and caregivers have more meaningful conversations about treatments. Our diabetes ads may look like pharmaceutical ads. The difference:  our disease ads are co-created by physicians and advertising professionals without financial conflicts of interest, in contrast to medical and disease information created by commercial communcation companies desinged to persuade people to use their clients treatments.

The feasibility of our approach was validated in a research study funded by the NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases).

Explore our ad-style education designed to improve care for older patients with diabetes.

Diabetes A1c Campaign During the 1990s and early 2000s, pharmaceutical companies sponsored 'educational' campaigns urging all patients with Type 2 diabetes to "aim" for an A1C of < 7%. At that time, the American American Diabetes Association (ADA) and the American Association of Endocrinology (AACE) also modified their guidelines, recommending an HbA1c <7 or lower for all patients. Now, in 2021, more professional assoications and researchers is harmful for vulnerable older patients. These diabetes ad concepts - co-developed by RxBalance, VA physicians and medical school professors - showcase the dangers of tight glycemic control.